Anthropic 称 Claude 已用于 6 家公司的真实药物项目
> Anthropic now uses Claude inside real drug programs at 6 companies and runs its own, including muscular dystrophy work that could reach human trials as soon a
Anthropic 表示，过去几个月其科学家与 6 家开发新药的组织建立了深度研究合作，同时启动了自家的药物发现工作。Claude 承担的工作不止于提出分子思路：约一个月内生成约 3.5 万个抗体设计，为一家单人生物技术公司协调 11 个外部实验室，并发现 7 个人类审阅者遗漏的生产问题。这些工作目前大多仍处于临床前阶段，Anthropic 自有项目中的一款药物最早可能在 2028 年底进入人体试验。
推荐理由
AI 评分 65
Anthropic 披露 Claude 在 6 家药企真实药物项目中的具体产出，可据此观察 AI 在药物研发链条上的实际分工。
主题
查看原帖过去几个月里，Anthropic 的科学家与六家开发新药的组织建立了深度研究合作关系。我们也启动了自己的药物发现工作。 在此过程中，我们对 Claude 如何支持药物开发的多个阶段有了更多了解。 在这篇博客文章中，我们分享这些工作中的一些早期成果，并说明这项工作如何与我们更广泛的生命科学雄心相契合。 https://t.co/EVbxkdDTgJ
查看原文
Over the past few months, Anthropic scientists have engaged in deep research partnerships with six organizations developing new medicines. We've also begun drug discovery efforts of our own. In doing so, we’ve learned much more about how Claude can support the many stages of drug development. In this blog post, we share some early results from these efforts, and describe how this work fits in with our wider ambitions in the life sciences. https://t.co/EVbxkdDTgJ
正文
> Anthropic now uses Claude inside real drug programs at 6 companies and runs its own, including muscular dystrophy work that could reach human trials as soon as late 2028.
> Claude handled far more than molecule ideas: it generated roughly 35K antibody designs in about a month, coordinated 11 outside labs for a one-person biotech, and caught 7 manufacturing issues human reviewers missed.
> The work remains mostly preclinical, though Anthropic’s in-house programs could put a drug into human trials as soon as late 2028.